Technical Analysis for INVA - Innoviva, Inc.

Grade Last Price % Change Price Change
grade B 14.51 0.69% 0.10
INVA closed up 0.69 percent on Friday, May 24, 2019, on 1.26 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Flat
See historical INVA trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Inside Day Range Contraction 0.00%
Fell Below 20 DMA Bearish 0.69%
Inside Day Range Contraction 0.69%
20 DMA Support Bullish -0.21%
MACD Bearish Signal Line Cross Bearish 0.07%
Crossed Above 20 DMA Bullish 0.07%
Fell Below 20 DMA Bearish 2.11%
Up 3 Days in a Row Strength -2.09%
50 DMA Support Bullish 2.33%

Older signals for INVA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Theravance, Inc., a royalty management company, is focused on developing respiratory products. It receives royalty revenues RELVAR/BREO ELLIPTA (fluticasone furoate/vilanterol, FF/VI), ANORO ELLIPTA (umeclidinium bromide/vilanterol, UMEC/VI), and VI monotherapy through the Long-Acting Beta2 Agonist collaboration agreement and the strategic alliance agreement with Glaxo Group Limited (GSK). The company is also entitled to a 15% interest in future payments made by GSK relating to the combination of UMEC/VI/FF and the Bifunctional Muscarinic Antagonist-Beta2 Agonist (MABA) program, as monotherapy, as well as in combination with other therapeutically active components, such as an inhaled corticosteroid, and other product or combination of products that might be discovered and developed under its LABA collaboration agreement with GSK. The company was formerly known as Advanced Medicine, Inc. and changed its name to Theravance, Inc. in April 2002. Theravance, Inc. was founded in 1996 and is headquartered in South San Francisco, California.
Medicine Drugs Glucocorticoids Organofluorides
Is INVA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.54
52 Week Low 13.07
Average Volume 907,036
200-Day Moving Average 15.5119
50-Day Moving Average 14.1472
20-Day Moving Average 14.5085
10-Day Moving Average 14.508
Average True Range 0.4018
ADX 12.99
+DI 19.0025
-DI 19.8417
Chandelier Exit (Long, 3 ATRs ) 14.0646
Chandelier Exit (Short, 3 ATRs ) 14.6354
Upper Bollinger Band 15.1495
Lower Bollinger Band 13.8675
Percent B (%b) 0.5
BandWidth 8.836199
MACD Line 0.0892
MACD Signal Line 0.1079
MACD Histogram -0.0188
Fundamentals Value
Market Cap 1.59 Billion
Num Shares 109 Million
EPS 0.80
Price-to-Earnings (P/E) Ratio 18.14
Price-to-Sales 7.61
Price-to-Book 0.00
PEG Ratio 0.22
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.96
Resistance 3 (R3) 14.96 14.81 14.89
Resistance 2 (R2) 14.81 14.70 14.81 14.86
Resistance 1 (R1) 14.66 14.62 14.74 14.66 14.83
Pivot Point 14.51 14.51 14.55 14.51 14.51
Support 1 (S1) 14.36 14.40 14.44 14.36 14.19
Support 2 (S2) 14.21 14.32 14.21 14.16
Support 3 (S3) 14.06 14.21 14.14
Support 4 (S4) 14.06